We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Kits Detect Dangerous Staphylococcal Exotoxins

By LabMedica International staff writers
Posted on 12 Nov 2008
A range of kits is available to detect bacterial exotoxins, including staphylococcal exotoxins that are primarily responsible for toxic shock syndrome (TSS).

Although TSS is relatively rare, it can be fatal. Generally caused by staphylococcus exotoxins, about 75% are caused by toxic shock syndrome toxin 1 (TSST-1) and 25% caused by staphylococcal enterotoxin B (SEB). Menstruating women, women using barrier contraceptive devices, postoperative patients, and burns patients are the most likely to suffer from TSS.

Some strains of Staphylococcus aureus do not produce toxins; therefore, the identification of S. aureus is not sufficient to attribute a case of TSS. But it is possible to confirm a clinical diagnosis by detecting the production of toxin in isolated strains. Oxoid (Basingstoke, UK) offers a range of kits for the detection of bacterial toxins, including the staphylococcal exotoxins. Toxic shock syndrome toxins can be detected reliably by reversed passive latex agglutination (RPLA) using Oxoid TST-RPLA (TD0940) for the detection of TSST-1 and Oxoid SET-RPLA (TD0900) for the detection of staphylococcal enterotoxins A, B, C, and D.

The RPLA toxin detection kits allow the presence of soluble antigen, such as bacterial toxins, to be detected visually by the agglutination of antibody-coated latex particles. Performed in V-well µl plates, a positive result is indicated by the formation of a clearly visible lattice structure. In the absence of a target antigen, the latex particles settle in a tight button in the bottom of the well.

Julie Elston, applications manager, clinical markets, Oxoid, commented, "Oxoid RPLA toxin detection kits allow clinical laboratories to detect bacterial toxins without the need for complicated equipment or special expertise. This could be of great value in determining the cause of toxic shock syndrome and may help in making therapeutic decisions as a wider choice of treatments become available.”

Oxoid is part of Thermo Fisher Scientific, Inc. (Louchborough, UK).

Related Links:
Oxoid
Thermo Fisher Scientific



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Chromogenic Culture System
InTray™ COLOREX™ ECC

Latest Microbiology News

Surveillance and Susceptibility Testing Track Rising Candida Auris in U.S.
12 Nov 2008  |   Microbiology

Plasma Cell-Free DNA Test Enables Earlier Diagnosis of Invasive Fungal Infections
12 Nov 2008  |   Microbiology

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection
12 Nov 2008  |   Microbiology